Comparative

OMIA group 540

Hypotrichosis, generic

The chain reaches the human disease hypotrichosis 2, which Mondo defines as: “Any hypotrichosis in which the cause of the disease is a mutation in the CDSN gene.” It reaches 6 more human diseases, listed below.

The chain

From the animal disease to the drugs. The page shows what each step found and where the chain stopped. It does not say whether the animal is a model of a human disease.

  1. Animal disease

    Reached

    OMIA records it in 12 species entries marked as a defect.

  2. Human disease

    Reached

    7 Mondo diseases.

  3. Human gene

    Stopped here

    No gene of a species entry marked as a defect reaches a human gene through Ensembl's orthologs.

  4. Target evidence

    Not reached

    The chain stopped before this step.

  5. Drugs

    Not reached

    The chain stopped before this step.

The chain stopped at Human gene: No gene of a species entry marked as a defect reaches a human gene through Ensembl's orthologs.

Natural-model score

How complete and how well supported the chain to each human disease is, out of 100, by stated rules. It does not say that the animal is a validated model of the human disease. How the score works.

hypotrichosis 2

15.0 out of 100

Part Computed from Points
Target evidence No Open Targets association with this disease 0.0 of 35
Drugs No drug has been tested for this disease, and none acts on its genes 0.0 of 25
Ortholog No gene of a naturally occurring entry reaches a human gene 0.0 of 20
Both routes One route found this disease 5.0 of 10
Species 12 naturally occurring species entries marked as a defect 10.0 of 10
hypotrichosis 4

15.0 out of 100

Part Computed from Points
Target evidence No Open Targets association with this disease 0.0 of 35
Drugs No drug has been tested for this disease, and none acts on its genes 0.0 of 25
Ortholog No gene of a naturally occurring entry reaches a human gene 0.0 of 20
Both routes One route found this disease 5.0 of 10
Species 12 naturally occurring species entries marked as a defect 10.0 of 10
Part Computed from Points
Target evidence No Open Targets association with this disease 0.0 of 35
Drugs No drug has been tested for this disease, and none acts on its genes 0.0 of 25
Ortholog No gene of a naturally occurring entry reaches a human gene 0.0 of 20
Both routes One route found this disease 5.0 of 10
Species 12 naturally occurring species entries marked as a defect 10.0 of 10
Part Computed from Points
Target evidence No Open Targets association with this disease 0.0 of 35
Drugs No drug has been tested for this disease, and none acts on its genes 0.0 of 25
Ortholog No gene of a naturally occurring entry reaches a human gene 0.0 of 20
Both routes One route found this disease 5.0 of 10
Species 12 naturally occurring species entries marked as a defect 10.0 of 10
Part Computed from Points
Target evidence No Open Targets association with this disease 0.0 of 35
Drugs No drug has been tested for this disease, and none acts on its genes 0.0 of 25
Ortholog No gene of a naturally occurring entry reaches a human gene 0.0 of 20
Both routes One route found this disease 5.0 of 10
Species 12 naturally occurring species entries marked as a defect 10.0 of 10
Part Computed from Points
Target evidence No Open Targets association with this disease 0.0 of 35
Drugs No drug has been tested for this disease, and none acts on its genes 0.0 of 25
Ortholog No gene of a naturally occurring entry reaches a human gene 0.0 of 20
Both routes One route found this disease 5.0 of 10
Species 12 naturally occurring species entries marked as a defect 10.0 of 10
Part Computed from Points
Target evidence No Open Targets association with this disease 0.0 of 35
Drugs No drug has been tested for this disease, and none acts on its genes 0.0 of 25
Ortholog No gene of a naturally occurring entry reaches a human gene 0.0 of 20
Both routes One route found this disease 5.0 of 10
Species 12 naturally occurring species entries marked as a defect 10.0 of 10

Species

The chain follows only the species entries that OMIA marks as a defect.

Species Scientific name OMIA entry A defect
American mink Neogale vison OMIA:000540-452646 Yes
dog Canis lupus familiaris OMIA:000540-9615 Yes
domestic cat Felis catus OMIA:000540-9685 Yes
domestic cattle Bos taurus OMIA:000540-9913 Yes
domestic guinea pig Cavia porcellus OMIA:000540-10141 Yes
golden hamster Mesocricetus auratus OMIA:000540-10036 Yes
macaques Macaca OMIA:000540-9539 Yes
meadow voles Microtus OMIA:000540-10053 Yes
Mongolian gerbil Meriones unguiculatus OMIA:000540-10047 Yes
pig Sus scrofa OMIA:000540-9823 Yes
rabbit Oryctolagus cuniculus OMIA:000540-9986 Yes
sheep Ovis aries OMIA:000540-9940 Yes

Genes

Each gene OMIA records for a species entry, and the human gene it reaches through Ensembl's orthologs.

Species Animal gene Human gene Ortholog
American mink No gene OMIA records no gene for this species entry.
dog No gene OMIA records no gene for this species entry.
domestic cat No gene OMIA records no gene for this species entry.
domestic cattle No gene OMIA records no gene for this species entry.
domestic guinea pig No gene OMIA records no gene for this species entry.
golden hamster No gene OMIA records no gene for this species entry.
macaques No gene OMIA records no gene for this species entry.
meadow voles No gene OMIA records no gene for this species entry.
Mongolian gerbil No gene OMIA records no gene for this species entry.
pig No gene OMIA records no gene for this species entry.
rabbit No gene OMIA records no gene for this species entry.
sheep No gene OMIA records no gene for this species entry.

Human diseases

Two routes lead from an OMIA group to a Mondo human disease: OMIA's own Mondo link, and the group's OMIM numbers through Mondo's cross-references.

Mondo disease Name Found by
MONDO:0007805 hypotrichosis 2 Any hypotrichosis in which the cause of the disease is a mutation in the CDSN gene. OMIA's OMIM numbers
MONDO:0100522 hypotrichosis 4 OMIA's OMIM numbers
MONDO:0009522 leukomelanoderma, infantilism, impaired intellectual development, hypodontia, hypotrichosis A rare ectodermal dysplasia syndrome characterized by congenital generalized melanoleukoderma, hypodontia and hypotrichosis associated with infantilism, intellectual disability and growth delay. There have been no further descriptions in the literature since 1961. OMIA's OMIM numbers
MONDO:0009601 metaphyseal dysplasia without hypotrichosis OMIA's OMIM numbers
MONDO:0008884 oculoosteocutaneous syndrome A syndrome is characterized by congenital anodontia, a small maxilla, short stature with shortened metacarpals and metatarsals, sparse hair, albinoidism and multiple ocular anomalies. It has been described in three siblings (one brother and two sisters). Transmission is autosomal recessive. OMIA's OMIM numbers
MONDO:0008469 spondyloepimetaphyseal dysplasia-hypotrichosis syndrome A rare primary bone dysplasia disorder characterized by congenital hypotrichosis associated with rhizomelic short stature (more pronounced in upper limbs than lower limbs), limited hip abduction and mild genu varum. Flared and irregular metaphyses, delayed and irregular epiphiseal ossification and pear-shaped vertebral bodies are characteristic radiologic findings. OMIA's OMIM numbers
MONDO:0010207 wooly hair-hypotrichosis-everted lower lip-outstanding ears syndrome OMIA's OMIM numbers

Target evidence

Each Open Targets association between one of the group's human genes and one of its human diseases, with its overall score and the score for each kind of evidence.

The chain did not reach target evidence.

Drugs

The chain did not reach the drugs.